Talena Ledón

Summary

Affiliation: Cuban Neuroscience Center
Country: Cuba

Publications

  1. ncbi Construction and characterisation of O139 cholera vaccine candidates
    Talena Ledón
    Grupo de Genética, Centro Nacional de Investigaciones Cientificas, AP 6412 Havana, Cuba
    Vaccine 21:1282-91. 2003
  2. ncbi Novel type of specialized transduction for CTX phi or its satellite phage RS1 mediated by filamentous phage VGJ phi in Vibrio cholerae
    Javier Campos
    Departamento de Genetica, Centro Nacional de Investigaciones Cientificas, AP 6412, Havana, Cuba
    J Bacteriol 185:7231-40. 2003
  3. ncbi TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera
    Talena Ledón
    Departamento de Biologia Molecular, Division de Enfermedades Infecciosas, Centro Nacional de Investigaciones Cientificas, Ave 25 Esq 158, AP 6412, La Habana, Cuba
    Microbes Infect 14:968-78. 2012
  4. ncbi El Tor and Calcutta CTXPhi precursors coexisting with intact CTXPhi copies in Vibrio cholerae O139 isolates
    Talena Ledón
    Departamento de Genetica, Centro Nacional de Investigaciones Cientificas, Ave 25 y 158, Playa, AP 6412, 10600 La Habana, Cuba
    Res Microbiol 159:81-7. 2008
  5. ncbi The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers
    Luis Garcia
    Centro Nacional de Investigaciones Cientificas, P O Box 6412, Avenida 25, Esquina a 158, Ciudad de La Habana, Cuba
    Infect Immun 73:3018-24. 2005
  6. ncbi VGJ phi, a novel filamentous phage of Vibrio cholerae, integrates into the same chromosomal site as CTX phi
    Javier Campos
    Departamento de Genetica, Centro Nacional de Investigaciones Cientificas, Havana, Cuba
    J Bacteriol 185:5685-96. 2003

Collaborators

Detail Information

Publications6

  1. ncbi Construction and characterisation of O139 cholera vaccine candidates
    Talena Ledón
    Grupo de Genética, Centro Nacional de Investigaciones Cientificas, AP 6412 Havana, Cuba
    Vaccine 21:1282-91. 2003
    ..These preliminary results pave the way for further clinical assays to confirm the possibilities of these vaccine prototypes as safe and effective tools for the prevention of O139 cholera...
  2. ncbi Novel type of specialized transduction for CTX phi or its satellite phage RS1 mediated by filamentous phage VGJ phi in Vibrio cholerae
    Javier Campos
    Departamento de Genetica, Centro Nacional de Investigaciones Cientificas, AP 6412, Havana, Cuba
    J Bacteriol 185:7231-40. 2003
    ..cholerae and the importance of our findings for the development of an environmentally safer live attenuated cholera vaccine...
  3. ncbi TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera
    Talena Ledón
    Departamento de Biologia Molecular, Division de Enfermedades Infecciosas, Centro Nacional de Investigaciones Cientificas, Ave 25 Esq 158, AP 6412, La Habana, Cuba
    Microbes Infect 14:968-78. 2012
    ....
  4. ncbi El Tor and Calcutta CTXPhi precursors coexisting with intact CTXPhi copies in Vibrio cholerae O139 isolates
    Talena Ledón
    Departamento de Genetica, Centro Nacional de Investigaciones Cientificas, Ave 25 y 158, Playa, AP 6412, 10600 La Habana, Cuba
    Res Microbiol 159:81-7. 2008
    ..We discuss the implications of these results in terms of the evolution and origin of the current diversity of CTXPhi prophages...
  5. ncbi The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers
    Luis Garcia
    Centro Nacional de Investigaciones Cientificas, P O Box 6412, Avenida 25, Esquina a 158, Ciudad de La Habana, Cuba
    Infect Immun 73:3018-24. 2005
    ..cholerae 3008. We recommend that additional vaccine lots of 638 be prepared under good manufacturing practices for further evaluation...
  6. ncbi VGJ phi, a novel filamentous phage of Vibrio cholerae, integrates into the same chromosomal site as CTX phi
    Javier Campos
    Departamento de Genetica, Centro Nacional de Investigaciones Cientificas, Havana, Cuba
    J Bacteriol 185:5685-96. 2003
    ..cholerae El Tor...